Advanced search
Publication Cover
Cell Adhesion & Migration Volume 7, 2013 - Issue 5
Submit an article Journal homepage
1,360
Views
35
CrossRef citations to date
0
Altmetric
Short Communication

Transplantation of umbilical cord and bone marrow-derived mesenchymal stem cells in a patient with relapsing-remitting multiple sclerosis

Zong-liu Hou Yan-an Hospital; Kunming Medical University; Kunming, PR China
,
Ying Liu Yan-an Hospital; Kunming Medical University; Kunming, PR China
,
Xi-Hong Mao Yan-an Hospital; Kunming Medical University; Kunming, PR China
,
Chuan-yu Wei Yan-an Hospital; Kunming Medical University; Kunming, PR China
,
Ming-yao Meng Yan-an Hospital; Kunming Medical University; Kunming, PR China
,
Yun-hong Liu Yan-an Hospital; Kunming Medical University; Kunming, PR China
,
Zara Zhuyun Yang The Key Laboratory of Stem Cell and Regenerative Medicine; Institute of Molecular and Clinical Medicine; Kunming Medical College; Kunming, PR China; Department of Anatomy and Developmental Biology; Monash University; Clayton, Victoria, Australia
,
Hongmei Zhu The Key Laboratory of Stem Cell and Regenerative Medicine; Institute of Molecular and Clinical Medicine; Kunming Medical College; Kunming, PR China; Department of Anatomy and Developmental Biology; Monash University; Clayton, Victoria, Australia
,
Martin Short Australian Regenerative Medicine Institute; Monash University; Clayton, VIC, Australia
,
Claude Bernard Department of Anatomy and Developmental Biology; Monash University; Clayton, Victoria, Australia
&
Zhi-cheng Xiao The Key Laboratory of Stem Cell and Regenerative Medicine; Institute of Molecular and Clinical Medicine; Kunming Medical College; Kunming, PR China; Australian Regenerative Medicine Institute; Monash University; Clayton, VIC, AustraliaCorrespondence[email protected]
 show all
Pages 404-407 | Received 15 Jul 2013, Accepted 24 Oct 2013, Published online: 30 Oct 2013

References

  • Uccelli A, Benvenuto F, Laroni A, Giunti D. Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 2011; 24:59 - 64; http://dx.doi.org/10.1016/j.beha.2011.01.004; PMID: 21396593
  • Dalous J, Larghero J, Baud O. Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives. Pediatr Res 2012; 71:482 - 90; http://dx.doi.org/10.1038/pr.2011.67; PMID: 22430384
  • Payne N, Siatskas C, Barnard A, Bernard CCA. The prospect of stem cells as multi-faceted purveyors of immune modulation, repair and regeneration in multiple sclerosis. Curr Stem Cell Res Ther 2011; 6:50 - 62; http://dx.doi.org/10.2174/157488811794480735; PMID: 20955155
  • Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, et al, Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008; 371:1579 - 86; http://dx.doi.org/10.1016/S0140-6736(08)60690-X; PMID: 18468541
  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8:315 - 7; http://dx.doi.org/10.1080/14653240600855905; PMID: 16923606
  • Meng MY, Pang W, Jiang LH, Liu YH, Wei CY, Xie YH, Yu HD, Hou ZL. Stemness gene expression profile analysis in human umbilical cord mesenchymal stem cells. Exp Biol Med (Maywood) 2012; 237:709 - 19; http://dx.doi.org/10.1258/ebm.2012.011429; PMID: 22728706
  • Freedman MS, Bar-Or A, Atkins HL, Karussis D, Frassoni F, Lazarus H, Scolding N, Slavin S, Le Blanc K, Uccelli A, MSCT Study Group. The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group. Mult Scler 2010; 16:503 - 10; http://dx.doi.org/10.1177/1352458509359727; PMID: 20086020
  • Payne NL, Sun G, McDonald C, Layton D, Moussa L, Emerson-Webber A, Veron N, Siatskas C, Herszfeld D, Price J, et al. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination. Cell Transplant 2013; 22:1409 - 25; http://dx.doi.org/10.3727/096368912X657620; PMID: 23057962
  • Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, Nakashima S, et al. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 2011; 13:675 - 85; http://dx.doi.org/10.3109/14653249.2010.549122; PMID: 21231804
  • Phillips JT, Giovannoni G, Lublin FD, O’Connor PW, Polman CH, Willoughby E, Aschenbach W, Pace A, Hyde R, Munschauer FE. Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis. Mult Scler 2011; 17:970 - 9; http://dx.doi.org/10.1177/1352458511399611; PMID: 21421809

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.